Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Paratek Pharmaceuticals To Be Acquired by Gurnet Point Capital And Novo Holdings For $3/Share Including Upfront Payment Of $2.15/Share; Total Transaction Consideration Of Up To ~$462M

Author: Benzinga Newsdesk | June 06, 2023 09:09am

Posted In: PRTK